Theratechnologies Inc. Files Form 6-K
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
TL;DR
Theratechnologies filed a 6-K on April 8th, check the press release for updates.
AI Summary
On April 8, 2025, Theratechnologies Inc. filed a Form 6-K report. This filing includes a press release dated April 8, 2025, as Exhibit 99.1. The company is based in Montreal, Quebec, Canada, and its fiscal year ends on November 30.
Why It Matters
This filing provides an update from Theratechnologies Inc., which could contain important information for investors regarding the company's operations or strategic developments.
Risk Assessment
Risk Level: low — This filing is a routine report and does not appear to contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- Theratechnologies Inc. (company) — Filer of the report
- April 8, 2025 (date) — Date of the press release and filing
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary who signed the report
- Montreal, Quebec, Canada (location) — Company's principal executive office location
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information that Theratechnologies Inc. has made or is required to make public in Canada, file or make public in the United States, or distribute to its security holders, as detailed in Exhibit 99.1, a press release dated April 8, 2025.
What is the filing date and period of report for this document?
The filing date and the conformed period of report for this document is April 8, 2025.
Who signed the report on behalf of Theratechnologies Inc.?
Jocelyn Lafond, General Counsel and Corporate Secretary, signed the report on behalf of Theratechnologies Inc.
What is the SIC code for Theratechnologies Inc.?
The Standard Industrial Classification (SIC) code for Theratechnologies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where are Theratechnologies Inc.'s principal executive offices located?
Theratechnologies Inc.'s principal executive offices are located at 2015 Peel Street, Suite 1100, Montreal, Quebec H3A 1T8, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 8, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..